Literature DB >> 8551201

Increased incidence of thyrotoxicosis in Malmö during the years 1988-1990 as compared to the years 1970-1974.

J Berglund1, U B Ericsson, B Hallengren.   

Abstract

OBJECTIVE AND
DESIGN: To compare the total and age-specific incidence of thyrotoxicosis, as well as the incidence of the individual types of thyrotoxicosis [i.e. thyrotoxicosis of Graves' type (GD), toxic nodular goitre (TNG) and solitary toxic adenoma (STA)] in Malmö during the years 1988-1990 to those of a previous study in 1970-1974.
SETTING: The town of Malmö in southern Sweden.
SUBJECTS: All patients from the Malmö population treated for thyrotoxicosis (GD, TNG and STA) for the first time during the 3-year period 1988-1990 were included.
RESULTS: Overall, 299 (263 females and 36 males) new cases of thyrotoxicosis were diagnosed in 1988-1990, corresponding to a mean annual incidence of thyrotoxicosis of 43.0 per 100,000 inhabitants. The incidence of GD was 22.3, of TNG 16.0 and of STA 4.8 per 100,000 per year. Comparing age- and sex-standardized incidences to the results in 1970-1974, there was a significant increase (P < 0.001) in the mean annual incidence of thyrotoxicosis in the total material as well as in TNG. In addition, there was an increase in GD in females younger than 50 years (P < 0.01), whereas in TNG/STA, an increase was seen in females of 50 years or older (P < 0.001). The incidence figures in males were not significantly changed. There was a higher proportion of smokers in females with GD compared to females with TNG (P < 0.001) and STA (P < 0.05).
CONCLUSIONS: The total incidence of thyrotoxicosis, as well as the incidence of GD in females younger than 50 years and the incidence of TNG/STA in females of 50 years or older, has increased in Malmö during the period from 1970 to 1990. The increase was probably caused by several factors such as more sensitive diagnostic tools and GD changes in smoking habits, but additional unknown factors might also be of importance.

Entities:  

Mesh:

Year:  1996        PMID: 8551201     DOI: 10.1046/j.1365-2796.1996.415757000.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  8 in total

Review 1.  The incidence and prevalence of thyroid autoimmunity.

Authors:  Donald S A McLeod; David S Cooper
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

2.  Results of surgery for toxic multinodular goiter.

Authors:  Antonio Ríos; José M Rodríguez; María D Balsalobre; Nuria M Torregrosa; Francisco J Tebar; Pascual Parrilla
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 3.  Global epidemiology of hyperthyroidism and hypothyroidism.

Authors:  Peter N Taylor; Diana Albrecht; Anna Scholz; Gala Gutierrez-Buey; John H Lazarus; Colin M Dayan; Onyebuchi E Okosieme
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

Review 4.  Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.

Authors:  Amanda Huber; Francesca Menconi; Sarah Corathers; Eric M Jacobson; Yaron Tomer
Journal:  Endocr Rev       Date:  2008-09-05       Impact factor: 19.871

5.  The incidence of thyroid function abnormalities and natural course of subclinical thyroid disorders, Tehran, I.R. Iran.

Authors:  H Delshad; L Mehran; M Tohidi; M Assadi; F Azizi
Journal:  J Endocrinol Invest       Date:  2011-09-30       Impact factor: 5.467

6.  cDNA immunization of mice with human thyroglobulin generates both humoral and T cell responses: a novel model of thyroid autoimmunity.

Authors:  Eric M Jacobson; Erlinda Concepcion; Kenneth Ho; Peter Kopp; Jussara Vono Toniolo; Yaron Tomer
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

7.  Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.

Authors:  P Perros; L Hegedüs; L Bartalena; C Marcocci; G J Kahaly; L Baldeschi; M Salvi; J H Lazarus; A Eckstein; S Pitz; K Boboridis; P Anagnostis; G Ayvaz; A Boschi; T H Brix; N Currò; O Konuk; M Marinò; A L Mitchell; B Stankovic; F B Törüner; G von Arx; M Zarković; W M Wiersinga
Journal:  Orphanet J Rare Dis       Date:  2017-04-20       Impact factor: 4.123

8.  Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials.

Authors:  David W Vaughn; Harry Seifert; Anne Hepburn; Walthere Dewe; Ping Li; Mamadou Drame; Catherine Cohet; Bruce L Innis; Louis F Fries
Journal:  Hum Vaccin Immunother       Date:  2014-11-21       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.